Clinical Study to Compare Efficacy and Safety of AVT29 and Eylea HD in Participants With Diabetic Macular Edema
Clinical trial NCT07489131 · RECRUITING
Trial details
- NCT number
- NCT07489131
- Sponsor
- Alvotech Swiss AG
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-22
- Primary completion
- 2027-07-01
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.